These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy. Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615 [TBL] [Abstract][Full Text] [Related]
25. Electroconvulsive therapy and Parkinson's disease: the case for further study. Kellner CH; Beale MD; Pritchett JT; Bernstein HJ; Burns CM Psychopharmacol Bull; 1994; 30(3):495-500. PubMed ID: 7878188 [No Abstract] [Full Text] [Related]
26. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature. Wilkins KM; Ostroff R; Tampi RR J Geriatr Psychiatry Neurol; 2008 Mar; 21(1):3-11. PubMed ID: 18287164 [TBL] [Abstract][Full Text] [Related]
28. Improvement of depression and parkinsonism during ECT: a case study. Dysken M; Evans HM; Chan CH; Davis JM Neuropsychobiology; 1976; 2(2-3):81-6. PubMed ID: 1012451 [TBL] [Abstract][Full Text] [Related]
29. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators. Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113 [TBL] [Abstract][Full Text] [Related]
30. Treatment of Parkinson's disease. Grieger TA; Cozza K; Armstrong S N Engl J Med; 1994 Mar; 330(9):643-4. PubMed ID: 8302357 [No Abstract] [Full Text] [Related]
31. Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease. Scicutella A J Neuropsychiatry Clin Neurosci; 2015; 27(1):e90. PubMed ID: 25716514 [No Abstract] [Full Text] [Related]
33. Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease. Burke WJ; Peterson J; Rubin EH Psychosomatics; 1988; 29(3):341-6. PubMed ID: 3406352 [No Abstract] [Full Text] [Related]
34. Electroconvulsive therapy in children and adolescents. Shoirah H; Hamoda HM Expert Rev Neurother; 2011 Jan; 11(1):127-37. PubMed ID: 21158560 [TBL] [Abstract][Full Text] [Related]
35. [Electroconvulsive therapy in neurologic diseases]. Folkerts H Nervenarzt; 1995 Apr; 66(4):241-51. PubMed ID: 7783810 [TBL] [Abstract][Full Text] [Related]
36. Letter to the editor: successful use of electroconvulsive therapy for refractory anxiety in Parkinson's disease. Marino L; Friedman JH Int J Neurosci; 2013 Jan; 123(1):70-1. PubMed ID: 23038993 [TBL] [Abstract][Full Text] [Related]
38. The use of ECT for Parkinson symptoms in a nondepressed patient. Berger M; de Soto DA Psychosomatics; 1990; 31(4):465-6. PubMed ID: 2247580 [No Abstract] [Full Text] [Related]
39. Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report. Kamigaichi R; Kubo S; Ishikawa K; Yokoyama K; Ogaki K; Usui C; Hatta K; Arai H; Mochizuki H; Hattori N Eur J Neurol; 2009 Feb; 16(2):e6. PubMed ID: 19146631 [No Abstract] [Full Text] [Related]
40. ECT and delirium in Parkinson's disease. Zervas IM; Fink M Am J Psychiatry; 1992 Dec; 149(12):1758; author reply 1759-60. PubMed ID: 1443265 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]